Literature DB >> 12478627

Prenatal diagnosis of 21-hydroxylase deficiency caused by gene conversion and rearrangements: pitfalls and molecular diagnostic solutions.

Rong Mao1, Lesa Nelson, Richard Kates, Christine E Miller, David L Donaldson, Wei Tang, Kenneth Ward.   

Abstract

OBJECTIVES: The present paper reports the prenatal diagnosis of congenital adrenal hyperplasia (CAH) in two cases of 21-hydroxylase deficiency. DNA diagnostic errors can be caused by the presence of the highly homologous 21-hydroxylase pseudogene, CYP21P, adjacent to the functional gene, CYP21. The present paper details how complex gene conversions and rearrangements between the CYP21 and CYP21P pose unique complications for prenatal diagnosis.
METHODS: Analysis of eight common mutations in the 21-hydroxylase gene as well as deletion of the entire gene is accomplished using polymerase chin reaction (PCR) followed by amplified created restriction site (ACRS) or allele-specific oligohybridization (ASO) and Southern blot followed by hybridization to a CYP21-specific probe. Linkage analysis was performed using microsatellite markers flanking the CYP21 gene.
RESULTS: The direct mutation detection assay indicated a complicated gene conversion and rearrangement in the probands of both families. Interpretation of these rearrangements made it difficult to determine whether or not the fetuses would be affected with CAH. Linkage studies revealed that each fetus had inherited both parental disease chromosomes and was therefore predicted to be affected with CAH.
CONCLUSION: As observed in the two reported cases, direct DNA analysis may provide limited information due to gene conversion or rearrangement between the CYP21 and CYP21P genes. These cases suggest that direct mutation detection should be supported by linkage analysis, whenever possible, to provide more comprehensive information for the family. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12478627     DOI: 10.1002/pd.467

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  5 in total

Review 1.  Congenital adrenal hyperplasia in pregnancy: approach depends on who is the 'patient'.

Authors:  Erin Keely; Janine Malcolm
Journal:  Obstet Med       Date:  2012-09-24

2.  Genotyping of CYP21A2 for congenital adrenal hyperplasia screening using allele-specific primer extension followed by bead array hybridization.

Authors:  Yongtaek Oh; Sung Won Park; Sung-Min Chun; Namkyoo Lim; Ki Sup Ahn; Jong-Ok Ka; Dong-Kyu Jin; Byoung-Don Han
Journal:  Mol Diagn Ther       Date:  2009-12-01       Impact factor: 4.074

3.  Novel method to characterize CYP21A2 in Florida patients with congenital adrenal hyperplasia and commercially available cell lines.

Authors:  Christopher N Greene; Suzanne K Cordovado; Daniel P Turner; Lisa M Keong; Dorothy Shulman; Patricia W Mueller
Journal:  Mol Genet Metab Rep       Date:  2014-08-08

4.  Prenatal diagnosis of steroid 21-hydroxylase-deficient congenital adrenal hyperplasia: Experience from a tertiary care centre in India.

Authors:  Sudhisha Dubey; Veronique Tardy; Madhumita Roy Chowdhury; Neerja Gupta; Vandana Jain; Deepika Deka; Pankaj Sharma; Yves Morel; Madhulika Kabra
Journal:  Indian J Med Res       Date:  2017-02       Impact factor: 2.375

Review 5.  Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia.

Authors:  Mahsa Kolahdouz; Zahra Mohammadi; Parisa Kolahdouz; Masoud Tajamolian; Hossein Khanahmad
Journal:  Adv Biomed Res       Date:  2015-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.